A flagellin-adjuvanted inactivated porcine epidemic diarrhea virus (PEDV) vaccine provides enhanced immune protection against PEDV challenge in piglets
A flagellin-adjuvanted inactivated porcine epidemic diarrhea virus (PEDV) vaccine provides enhanced immune protection against PEDV challenge in piglets
复制标题
鞭毛蛋白佐剂灭活猪流行性腹泻病毒 (PEDV) 疫苗可增强仔猪针对 PEDV 攻击的免疫保护
DOI:
10.1007/s00705-020-04567-w
复制
发表时间:
2020
影响因子:
2.7
通讯作者:
Bin Li
中科院分区:
文献类型:
--
作者:
Xiangwei Xu;Luping Du;Baochao Fan;Bing Sun;Jinzhu Zhou;Rongli Guo;Zhengyu Yu;Danyi Shi;Kongwang He;Bin Li
Since late 2010, outbreaks of porcine epidemic diarrhea (PED) have been reported in the swine industry in China. A variant PEDV strain that differs from strain CV777 causes prevalent PEDV infections which commercial vaccines based on CV777 cannot provide complete protection. In this study, we designed a new vaccine based on the epidemic PEDV strain AH2012/12, adjuvanted with flagellin, a mucosal adjuvant that induces mucosal and systemic production of IgA. Three groups of pregnant sows were immunized twice, with a 14-day interval, with PEDV adjuvanted with flagellin, PEDV alone, or PBS before farrowing, and newborn piglets from each group were selected and challenged with PEDV. Immunization with this vaccine elicited high levels of IgG, IgA, and neutralizing antibodies in the serum and colostrum of sows, and newborn piglets were protected against PEDV while suckling. This study should guide the prevention and control strategies for PEDV infection, thereby reducing the losses associated with this virus.